Yujie Wang

2.4k total citations · 1 hit paper
111 papers, 1.7k citations indexed

About

Yujie Wang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yujie Wang has authored 111 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Molecular Biology, 30 papers in Cancer Research and 12 papers in Oncology. Recurrent topics in Yujie Wang's work include Cancer-related molecular mechanisms research (16 papers), RNA and protein synthesis mechanisms (12 papers) and RNA modifications and cancer (12 papers). Yujie Wang is often cited by papers focused on Cancer-related molecular mechanisms research (16 papers), RNA and protein synthesis mechanisms (12 papers) and RNA modifications and cancer (12 papers). Yujie Wang collaborates with scholars based in China, United States and Hong Kong. Yujie Wang's co-authors include Xingya Wang, Dandan Guo, Cuiling Guo, Tingting Sang, Chengjie Guo, Liu Fang, Jiajun Chen, Rong Chen, Ying Wang and Chaojie Chen and has published in prestigious journals such as Nature Communications, The Journal of Chemical Physics and PLoS ONE.

In The Last Decade

Yujie Wang

104 papers receiving 1.6k citations

Hit Papers

Ganoderma lucidum polysaccharide modulates gut microbiota... 2021 2026 2022 2024 2021 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yujie Wang China 21 872 281 169 163 143 111 1.7k
Jeong Ho Seok South Korea 26 980 1.1× 217 0.8× 161 1.0× 188 1.2× 151 1.1× 64 1.7k
Mingming Li China 24 891 1.0× 285 1.0× 115 0.7× 215 1.3× 195 1.4× 127 1.9k
Ju‐Hee Kang South Korea 23 800 0.9× 188 0.7× 217 1.3× 173 1.1× 260 1.8× 67 1.5k
Jiong Hu China 23 1.1k 1.3× 366 1.3× 161 1.0× 230 1.4× 159 1.1× 72 2.3k
Xiyu Zhang China 26 1.2k 1.3× 322 1.1× 194 1.1× 165 1.0× 239 1.7× 94 2.3k
Yanjun Zheng China 23 803 0.9× 266 0.9× 99 0.6× 214 1.3× 162 1.1× 61 1.7k
Yoosik Yoon South Korea 29 948 1.1× 175 0.6× 214 1.3× 269 1.7× 149 1.0× 85 2.0k
Kathy K. W. Au-Yeung Hong Kong 25 915 1.0× 236 0.8× 140 0.8× 202 1.2× 160 1.1× 41 1.9k
Wen‐Bin Wu Taiwan 27 851 1.0× 179 0.6× 125 0.7× 290 1.8× 149 1.0× 100 2.2k
Jiaqi Zhang China 22 752 0.9× 179 0.6× 80 0.5× 161 1.0× 151 1.1× 101 1.6k

Countries citing papers authored by Yujie Wang

Since Specialization
Citations

This map shows the geographic impact of Yujie Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yujie Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yujie Wang more than expected).

Fields of papers citing papers by Yujie Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yujie Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yujie Wang. The network helps show where Yujie Wang may publish in the future.

Co-authorship network of co-authors of Yujie Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yujie Wang. A scholar is included among the top collaborators of Yujie Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yujie Wang. Yujie Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jun, Jie Ma, Ruiyuan Cao, et al.. (2025). A skin organoid-based infection platform identifies an inhibitor specific for HFMD. Nature Communications. 16(1). 2513–2513. 3 indexed citations
2.
Li, Yuanyuan, Han Qiu, Qiwen Sun, et al.. (2025). Discovery of highly potent mTOR inhibitors aimed at suppressing the progression of acute myeloid leukemia. Bioorganic Chemistry. 157. 108287–108287. 1 indexed citations
3.
Gong, Sha, et al.. (2025). Gene Regulation by a Kinetic Riboswitch with Negative Feedback Loop. The Journal of Physical Chemistry B. 129(9). 2348–2358. 2 indexed citations
4.
Yang, Liping, et al.. (2024). Wnt2bb signaling promotes pharyngeal chondrogenic precursor proliferation and chondrocyte maturation by activating Yap expression in zebrafish. Journal of genetics and genomics. 52(2). 220–230. 1 indexed citations
5.
Deng, Tingting, Xingxing Wu, Yujie Wang, Xiaoqin Fan, & Bing Hu. (2024). Toe1 promotes proliferation and differentiation of neural progenitor cells. Heliyon. 10(20). e39535–e39535. 2 indexed citations
6.
Yang, Shenmiao, Haiwen Huang, Keshu Zhou, et al.. (2024). Acalabrutinib in Chinese patients with relapsed/refractory chronic lymphocytic leukemia: Primary analysis from an open-label, multicenter phase 1/2 trial. Annals of Hematology. 104(1). 701–712. 1 indexed citations
7.
Cui, Yong, Yujie Wang, Qingjie Zeng, et al.. (2024). Epigenetic regulation of H3K27me3 in laying hens with fatty liver hemorrhagic syndrome induced by high-energy and low-protein diets. BMC Genomics. 25(1). 374–374. 2 indexed citations
8.
Zhang, Nana, Yujie Wang, Siyu He, et al.. (2023). Virtual screening of novel mTOR inhibitors for the potential treatment of human colorectal cancer. Bioorganic Chemistry. 140. 106781–106781. 6 indexed citations
9.
Chen, Hongsong, Jing Mi, Sen Li, et al.. (2023). Design, synthesis and evaluation of quinoline- O -carbamate derivatives as multifunctional agents for the treatment of Alzheimer’s disease. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2169682–2169682. 25 indexed citations
10.
Zhang, Jiaman, et al.. (2023). Profiling of Chromatin Accessibility in Pigs across Multiple Tissues and Developmental Stages. International Journal of Molecular Sciences. 24(13). 11076–11076. 8 indexed citations
11.
Wang, Yujie, et al.. (2023). Exploring genetic associations between allergic diseases and indicators of COVID-19 using mendelian randomization. iScience. 26(6). 106936–106936. 5 indexed citations
12.
Xiao, Li, Hengrui Hu, Wanlin Liu, et al.. (2023). SARS-CoV-2-infected hiPSC-derived cardiomyocytes reveal dynamic changes in the COVID-19 hearts. Stem Cell Research & Therapy. 14(1). 361–361. 1 indexed citations
14.
Li, Hang, Yujie Wang, Qi Liu, et al.. (2022). Highly efficient TiO2-based one-step strategy for micro volume plasma-derived extracellular vesicles isolation and multiomics sample preparation. International Journal of Mass Spectrometry. 483. 116971–116971. 5 indexed citations
15.
Li, Jun, Jie Ma, Qiyu Zhang, et al.. (2022). Spatially resolved proteomic map shows that extracellular matrix regulates epidermal growth. Nature Communications. 13(1). 4012–4012. 40 indexed citations
16.
Bai, Yuanyuan, Yuanyuan Chen, Xuejing Sun, et al.. (2022). Development and validation of a novel risk score to predict 5-year mortality in patients with acute myocardial infarction in China: a retrospective study. PeerJ. 9. e12652–e12652. 1 indexed citations
17.
Liu, Taigang, et al.. (2021). Thermodynamic and kinetic properties of a single base pair in A-DNA and B-DNA. Physical review. E. 103(4). 42409–42409. 8 indexed citations
18.
Ma, Jie, Jia Liu, Dunqin Gao, et al.. (2021). Establishment of Human Pluripotent Stem Cell‐Derived Skin Organoids Enabled Pathophysiological Model of SARS‐CoV‐2 Infection. Advanced Science. 9(7). e2104192–e2104192. 42 indexed citations
19.
Zhao, Jing, Lei Jin, Yujie Wang, et al.. (2017). A functional variant in the 3ˈ-UTR of VEGF predicts the 90-day outcome of ischemic stroke in Chinese patients. PLoS ONE. 12(2). e0172709–e0172709. 10 indexed citations
20.
Huang, Xiaolei, et al.. (2016). Application of Sequential Cluster Analysis and Periodogram Method in Epidemic Trend Analysis of Scarlet Fever. 33(6). 925. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026